Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.
200k per annum captivity at its US facility.
I imagine this number will increase soon.
If we use that capacity up (not hard to imagine) then that's 140m revenue.
Then add in the other news that's likely to come out of their episwitch platform for other cancers.
The BOD have proper skin in the game and added a lot higher up than 40p. They want reward for their 10 years of work so I expect them to limit further dilution wherever possible.
OBD is in a very enviable position. Real inflection point happening here
Key features of the Fundraising
· The Fundraising will provide working capital to support the commercial development, through continued investment in sales and marketing activities to grow adoption of EpiSwitch® CiRT and spending to complete the validation, launch and initial sales and marketing support of PSE.
Lol. Wow just seen who crawled out today from nowhere haha. Happens on every stock that's done well. I see it as a positive really
No chance this goes back in the 30s.
If people want entry or to add it looks like low 40s the place.
The more I've processed what OBD have with EpiSwitch the more I'm realizing how much this company will be valued at in the coming years. Genuinely see this being a multi billion pharma company.
Could be the latest and best success story of AIM